From: Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis
Baseline
After 12 Months
N
%
No
76
26.1%
148
50.9%
≤ 5 days
26
8.9%
27
9.3%
6–10 days
39
13.4%
14
4.8%
11–20 days
32
11.0%
8
2.8%
> 20 days
50
17.2%
18
6.2%
Not in employment
68
23.4%
62
21.3%
Missing information
0
0%